Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE American: MTNB) announced today that on June 24, 2026, it received a notice (the “Notice”) ...
Reporting obligations were automatically suspended by statute on January 1, 2026; Form 15 filed as formal notice to the SEC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results